Hong Kong CNN —US drugmaker Moderna has signed a deal to make mRNA medicines in China as part of its first major investment in the country, despite escalating trade and political tension between Washington and Beijing.
The company currently only markets its mRNA vaccines for Covid-19, but has a number of vaccines and therapeutics in its pipeline.
Those focus on addressing infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and autoimmune diseases, according to the company.
Moderna’s Covid-19 vaccine, which received emergency authorization from US regulators in 2020 and full approval in 2022, has not been approved in China.
For most of the pandemic, China relied on more traditional platforms for its homegrown Covid-19 vaccines.
Persons:
Yicai, Janet Yellen, Biden, Moderna’s, Johnson
Organizations:
Hong Kong CNN, CNN, Xinhua, CSPC Pharmaceutical Group, Pfizer
Locations:
Hong Kong, China, Washington, Beijing, The Cambridge , Massachusetts, Shanghai’s Minhang, Shijiazhuang